Advanced Micro-Fabrication Equipment China (SHA:688012) completed the acquisition of a 64.69% stake in Hangzhou Zhonggui Electronic Technology, moving forward with its share-and-cash acquisition plan.
The company will now issue new shares to transaction counterparties and issue shares to raise supporting funds, according to a Sunday filing with the Shanghai bourse.
Shares of the chip gear maker declined 6% in recent trade.
Huaneng Lancang River Hydropower (SHA:600025) completed the issuance of two green bonds, according to a Saturday filing on the Shanghai bourse.The company issued its sixth green super short-term commercial paper worth 1.4 billion yuan, with a coupon rate of 1.37% and a term of 168 days.The company also issued its seventh green medium-term bond for the year, which amounted to 1.6 billion yuan. It has a term of three years and a coupon rate of 1.55%.The hydropower company's shares rose 1% during Monday's morning trade.
Old Chang Kee's (SGX:5ML) profit for the fiscal second half ended March 31 fell by 12% to SG$4.5 million from SG$5.1 million a year earlier, according to a Friday filing with the Singapore Exchange.Earnings per share dropped to SG$0.0374 compared with SG$0.0422 in the year-ago period.The food and beverage company's revenue inched up 2.8% year over year to SG$51.5 million from SG$50.1 million.
Hanmi Pharm (KRX:128940) granted Eli Lilly worldwide exclusive rights to develop, produce, and market the South Korean drug company's sonefpeglutide biologic drug candidate, according to a Monday news release in Seoul.The rights do not cover Korea, according to Hanmi.Hanmi is set to receive a $75 million upfront payment from the U.S. drug company and an additional $1.19 billion in milestone payments from clinical development, regulatory approval, and commercialization.The South Korean drug company will also be eligible for royalties following the launch.Sonefpeglutide is a long-acting glucagon-like peptide 2 or GLP-2 that helps with intestinal growth. GLP-2 obtained approval for short bowel syndrome.Shares rose 6% during afternoon trading on Monday.